Percentage of core lengths involved with prostate cancer: Does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?

Urology

Volumn 59, Issue 5, 2002, Pages 704-708

  Linson, Patrick W ^a   Lee, Andrew K ^a   Doytchinova, Tatiana ^b   Chen, Ming Hui ^b   Weinstein, Michael H ^c   Richie, Jerome P ^c   D'Amico, Anthony V ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Worcester Polytechnic Institute   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REGRESSION ANALYSIS; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; HUMANS; MALE; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 0036242914     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01665-X     Document Type: Article

References (15)

1. Cancer statistics
2. Radiation therapy for clinically localized prostate cancer: Multi-institutional pooled analysis
3. A validated system for predicting PSA outcome following radical prostatectomy in the PSA era: 10 year results
4. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
5. Use of Gleason score, prostate specific antigen, seminal vesicle, and margin status to predict biochemical failure after radical prostatectomy
6. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?
7. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate
8. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
9. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: Results from the cancer of the prostate strategic urologic research endeavor database
10. Histologic grading and staging of prostate carcinoma
11. Simultaneous inferences and other topics in regression analysis-1
12. Nonparametric estimation from incomplete observations
13. Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy
14. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal examination, prostate specific antigen and the results of 6 systematic biopsies
15. Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer